Global S&T Development Trend Analysis Platform of Resources and Environment
Manufacturing of life-enhancing medicines boosted by new government funding | |
admin | |
2018-11-22 | |
发布年 | 2018 |
语种 | 英语 |
国家 | 英国 |
领域 | 气候变化 |
正文(英文) | Press release Manufacturing of life-enhancing medicines boosted by new government fundingPatients could receive faster treatment following boost to streamline the production of medicines and treatments. ![]()
Patients could soon receive faster treatment thanks to a multi-million pound government boost to streamline the production of medicines and treatments, including those used to treat blood cancers and inherited disorders. Companies in Northumberland, Oxford and London will adopt new digital technologies, such as artificial intelligence, to support the manufacture of next-generation medicines and treatments. The £4.3 million funding aims to create more efficient and innovative methods for manufacturing medicines. The challenge works to set the UK apart as a leader with greater capacity for manufacture of safe, affordable and effective therapies. Life Sciences Minister Lord Henley said:
The 3 individual projects are:
One year on from the launch of the Industrial Strategy, this £7.3 million investment is the latest commitment from the £180 million Industrial Strategy Challenge Fund (ISCF) dedicated to leading-edge Medicines Manufacturing. Taking steps to improve patient access to life-saving treatments and medicines, Advanced Therapy Treatment Centres, working across the UK, will support the roll-out of cell and gene therapies as clinical trials show them to be safe and cost-effective. The centres bring together expert clinicians, researchers, scientists, developers and private companies to demonstrate how the therapies have impact on patients’ lives. Advanced therapies, including cell and gene therapies, represent the next generation of therapies that have the potential to offer treatments for a number of conditions including some blood cancers and inherited conditions for which there are currently limited treatment options. UK Research and Innovation (UKRI) is responsible for managing the Industrial Strategy Challenge Fund, which funds the winners of the Medicines Manufacturing Challenge. Dr Ian Campbell, Interim Executive Chair, Innovate UK for UKRI, said:
Notes for editorsThe projects awarded funding in the Digitalisation of Medicines Manufacturing are:
The Advanced Therapy Treatment Centres have been established previously by £21 million funding from the Industrial Strategy Challenge Fund and are working to develop systems and methodologies that will allow the delivery of advanced therapies across the healthcare system. The Advanced Therapy Treatment Centres are:
The Cell and Gene Therapy Catapult is playing a key role in the coordinating the work of the 3 Advanced Therapy Treatment Centres to ensure that learning and best practice is shared effectively. They will allow the creation of bespoke manufacturing and supply systems capable of operating across the entire NHS with the potential to treat many patients each month.
Published 22 November 2018
|
URL | 查看原文 |
来源平台 | GOV.UK - Department for Business, Energy & Industrial Strategy |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/105481 |
专题 | 气候变化 |
推荐引用方式 GB/T 7714 | admin. Manufacturing of life-enhancing medicines boosted by new government funding. 2018. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论